Cargando…
Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trial
Autores principales: | Fenwarth, Laurène, Duployez, Nicolas, Marceau-Renaut, Alice, Chahla, Wadih Abou, Ducassou, Stéphane, Gandemer, Virginie, Pasquet, Marlène, Leblanc, Thierry, Schneider, Pascale, Domenech, Carine, Saultier, Paul, Leverger, Guy, Lapillonne, Hélène, Preudhomme, Claude, Petit, Arnaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928013/ https://www.ncbi.nlm.nih.gov/pubmed/32554555 http://dx.doi.org/10.3324/haematol.2020.248872 |
Ejemplares similares
-
Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group
por: Lew-Derivry, Lucille, et al.
Publicado: (2023) -
Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group
por: Marceau-Renaut, Alice, et al.
Publicado: (2018) -
Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group
por: Blais, S., et al.
Publicado: (2019) -
Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial
por: Petit, Arnaud, et al.
Publicado: (2018) -
Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study
por: Gouache, Elodie, et al.
Publicado: (2018)